Skip to primary navigation Skip to main content
0 item $0.00

Dr Andrea Douglas is the Vice President, R&D Strategy and External Affairs at CSL Limited

Andrea Douglas leads CSL’s Organisation Transformation Office, which integrates and drives major organisational design changes that have broad implications to the business across areas of strategy, structure, governance, process and people. She also leads government relations strategy in Australia.

Andrea has held various roles at CSL since 2005, including Vice President, R&D Strategy and External Affairs where she led the global R&D strategy, product portfolio, R&D investment and prioritisation processes. She was also Vice President, Licensing, Head of Global R&D Project Management and Program Director, Influenza.

Before joining CSL Andrea was the CEO of the Gene CRC. She also held a senior research role at WEHI where she studied the molecular genetics of breast cancer.

Andrea has a PhD degree in Forensic Medicine from Monash University. She also holds a Masters degree in Health Administration and is a Graduate of the Australian Institute of Company Directors. She is a Director of the Baker Heart and Diabetes Institute and BioCurate and was a Director of AusBiotech from 2013–2019.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more